跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RANOLAZINA CINFA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RANOLAZINA CINFA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
RANOLAZINA CINFA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Laboratorios Cinfa S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 29, 2022
Approval ID
5fef35f2ad6116c7
Company
Laboratorios Cinfa S.A.
Type
Standard
Approval Details
Approval Id
5fef35f2ad6116c7
Drug Cima Aemps Name
RANOLAZINA CINFA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
88005
Holder Company Name
Laboratorios Cinfa S.A.
Marketing Company Name
Laboratorios Cinfa S.A.
Authorization Date
2022-07-29
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
375 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Cinfa S.A.
Active Ingredients
RANOLAZINA
375 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 29, 2022
Approval ID
5fef35f2ad6116c7
Type
Standard
Back to CIMA-AEMPS Approvals